By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Horizon Pharma plc 

Connaught House, 1st Floor
1 Burlington Road
Dublin 4      Ireland
Phone: +353-1-72-2100 Fax:


SEARCH JOBS








Company News
Why Horizon Pharma (HZNP) Gained As Much As 13.1% Yesterday 8/18/2017 6:32:18 AM
Horizon Pharma (HZNP) Launches CGD Connections To Deliver Support And Resources Created By And For The Chronic Granulomatous Disease (CGD) Community 7/25/2017 11:16:15 AM
Horizon Pharma (HZNP) Announces Four Poster Presentations On PROCYSBI (Cysteamine Bitartrate) Delayed-Release Capsules At Cystinosis Research Network 2017 Family Conference 7/14/2017 6:06:34 AM
Horizon Pharma (HZNP) Announces District Court Decision To Uphold VIMOVO (Naproxen/Esomeprazole Magnesium) Patents 6/27/2017 11:15:37 AM
Horizon Pharma (HZNP) Announces Health Canada Approval Of PROCYSBI (Cysteamine Delayed-Release Capsules) For The Treatment Of Nephropathic Cystinosis 6/19/2017 8:34:27 AM
Horizon Pharma (HZNP) Release: Epidemiologic Study Findings Show Over 400 Percent Increase In Gout Patient Hospitalizations Since 1993 6/14/2017 12:20:47 PM
Horizon Pharma (HZNP) Presents New Data Analyses Further Demonstrating Clinical Benefit Of KRYSTEXXA (Pegloticase) In Patients With Uncontrolled Gout 6/14/2017 11:57:14 AM
Horizon Pharma (HZNP) Pays $145 Million For River Vision And Its Rare Eye Disease Drug 5/8/2017 6:04:43 AM
Horizon Pharma (HZNP) To Present Data On RAVICTI (Glycerol Phenylbutyrate) Oral Liquid For Urea Cycle Disorder Patients Aged Two Months To Two Years 3/22/2017 8:51:33 AM
Horizon Pharma (HZNP) Release: Global Genes And Company Partner To Offer Nephropathic Cystinosis Scholarships 1/18/2017 10:16:39 AM
12345678910...
//-->